Abstract
BackgroundAlpelisib is a recently approved treatment for hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer. It has been ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
